Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Romain Marignier, Markus Reindl et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 297
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Thor Petersen, Tove Christensen et al.|Neurology|2018Cited by 104
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Stella Hughes et al.|JAMA Neurology|2023Cited by 62
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)Morten Riemenschneider, Ulrik Dalgas, Lars G. Hvid et al.|Multiple Sclerosis Journal|2022Cited by 48
Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countriesViktoria Papp, Zsolt Illés, Kim D.P. Trones et al.|Multiple Sclerosis and Related Disorders|2021Cited by 8